Plant cell culture technologies
The industrial exploitation of plant cell, tissue and organ cultures is now a actuality and the brand new applied sciences are already in place and creating quickly. Their emergence has supplied new views and sharpened the main focus of the methods through which plant cell and tissue tradition can assist man. Along with the thrilling new developments in plant molecular biology, these in vitro procedures ought to enable plant bio technologists to ‘design’ crops and plant merchandise and exploit the total industrial potential of plant cell cultures.
PROPERTIES
High quality Stage
200
organic supply
algae (Rhodophyceae)
type
powder
utility(s)
cell tradition | mammalian: appropriate
cell tradition | plant: appropriate
microbiology: appropriate
transition temp
congealing temperature <38 °C (1.5% in H2O)
suitability
microbiology examined
Featured Business
Agriculture
storage temp.
room temp
DESCRIPTION
Common description
Utility
Agar has been used:
- as a reference commonplace industrial agar to match the physio-chemical, gelling properties of alkali-treated agar from Gracilaria tenuistipitata
- as a part within the seed germination medium and rooting medium for commercially obtainable soybean (Glycine max (L.) Merr) seeds
- as a part of development media for B. subtilis mutant pressure MTC871 based mostly biofilm colonies
- as a bacteriological agar part to arrange half power Murashige-Skoog (MS 50%) medium for Echinocactus platycanthus seeds tradition

Typical working focus: 6-12g/L.
Packaging
Biochem/physiol Actions
Different Notes
Bacterial Ailments
Some micro organism inflicting infecting Hashish crops embrace Pseudomonas syringae and Xanthomonas campestris pv. Hashish. The signs of Pseudomonas syringae are small water-soaked leaf spots which will enlarge alongside the veins, turning brown. The Xanthomonas campestris causes leaf spots and wilting in crops.
Fungal Ailments
A few of the main hashish infecting fungus and ailments attributable to them are:
- Fusarium oxysporum f.sp. Hashish causes wilt whose signs embrace yellowing of leaves, poor development, and wilt.
- Pythium illness causes root rot and damping-off illness whose signs fluctuate from small roots lesions, extreme root injury, stunted development, to yellowing of leaves. Additional, damping-off impacts younger seedlings.
- Sclerotinia sclerotiorum causes hemp canker whose preliminary signs embrace watersoaked lesions on stalks and branches that may later trigger cankers. Generally cottony white mycelium and black sclerotia may seem.
- Sphaeorotheca macularis or Leveillula taurica causes powdery mildew. It’s one of the crucial widespread foliar ailments of hashish. Its signs embrace powdery development on the floor of leaves that later turns brown.
- The hashish plant can be affected by Alternaria species, which causes leaf spot and brown blight ailments.
Viral and Viroid Ailments
Viruses affecting hashish embrace Hop mosaic virus (HpMV), Apple mosaic virus (ApMV), Hop stunt viroid (HSVd), Hop latent viroid, Arabis mosaic virus (ArMV), Alfalfa mosaic virus (AMV), Tobacco mosaic virus (TMC), Cucumber mosaic virus (CMV), and phytoplasmas.
The viruses may cause extreme crop losses, cut back development, or have an effect on the yield and high quality of crops. The widespread signs of viruses embrace yellow and inexperienced mosaic patterns on the leaves of Hashish and curling, distortion, and narrowing of younger leaves. Phytoplasmas primarily trigger extreme shoot proliferation and stunted development.
![]() CD273 Recombinant Protein |
|||
RF16020-01 | ProSci | 0.1 mg | EUR 619.8 |
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
![]() Mouse Anti-Human CD273 (PD-L2) mAbConjugated Antibody |
|||
CCM031 | SAB | 100ul | EUR 476.4 |
![]() Anti-Hu CD273 PE |
|||
1P-178-T025 | ExBio | 25 tests | EUR 168 |
![]() Anti-Hu CD273 PE |
|||
1P-178-T100 | ExBio | 100 tests | EUR 288 |
![]() Anti-Hu CD273 APC |
|||
1A-178-T100 | ExBio | 100 tests | EUR 288 |
![]() Anti-Hu CD273 Purified |
|||
11-178-C025 | ExBio | 0.025 mg | EUR 118.8 |
![]() Anti-Hu CD273 Purified |
|||
11-178-C100 | ExBio | 0.1 mg | EUR 189.6 |
![]() Mouse Anti-Human CD273 (PD-L2) mAb |
|||
CM031-100ug | SAB | 100ug | EUR 250.8 |
![]() Mouse Anti-Human CD273 (PD-L2) mAb |
|||
CM031-25ug | SAB | 25ug | EUR 154.8 |
![]() Anti-Hu CD273 Alexa Fluor647 |
|||
A6-178-T100 | ExBio | 100 tests | EUR 322.8 |
![]() CD273 [PD-L2] Recombinant Protein |
|||
90-425 | ProSci | 100 ug | EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
![]() CD273 [PD-L2] Recombinant Protein |
|||
90-427 | ProSci | 100 ug | EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
![]() CD273 [PD-L2] Recombinant Protein |
|||
90-428 | ProSci | 100 ug | EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
![]() Anti-Hu CD273 PE-Cy7 |
|||
T7-178-T100 | ExBio | 100 tests | EUR 321.6 |
![]() Recombinant Mouse PD-L2/B7-DC/CD273 Protein |
|||
RP00660 | Abclonal | 10 μg | EUR 174 |
![]() PD-L2 (CD273), Fc fusion (Human) |
|||
71107 | BPS Bioscience | 100 µg | EUR 330 |
Description: Human secreted Programmed Death Ligand 2 (PD-L2)-Fc fusion protein, also known as CD273, PDCDL1G2, and B7-DC, GenBank Accession No. NM_025239, a.a. 20-219, fused at the C-terminus to the Fc portion of human IgG1 expressed in a HEK293 cell expression system. MW = 49 kDa. |
![]() Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx140405-01mg | Abbexa | 0.1 mg | EUR 427.2 |
![]() Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx414420-02mg | Abbexa | 0.2 mg | EUR 678 |
![]() Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx414421-01mg | Abbexa | 0.1 mg | EUR 526.8 |
![]() Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx412031-01mg | Abbexa | 0.1 mg | EUR 610.8 |
![]() Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx414235-025mg | Abbexa | 0.25 mg | EUR 678 |
![]() Anti-CD273/ PD-L2 Antibody [TY25], Unconjugated-100ug |
|||
QAB101-100ug | EnQuireBio | 100ug | EUR 270 |
![]() PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
R32447 | NSJ Bioreagents | 100 ug | EUR 419 |
![]() PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
![]() PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
![]() PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
![]() PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7546-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
![]() PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7546-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |